Market Research Logo

Global Crohn's Disease (CD) Market 2015-2019

Global Crohn's Disease (CD) Market 2015-2019

About CD

CD is an ongoing condition that causes inflammation of the digestive tract or the GI tract. CD may also be named as ileitis, granulomatous enteritis or colitis, regional enteritis, or terminal ileitis. The exact etiology of CD is unknown. Usually, CD affects the small intestine and the beginning of the large intestine. However, the disease can disturb any part of the GI tract, from the mouth to the anus. CD can occur at any age; however, it is usually first diagnosed in people in their teens and twenties.

TechNavio's analysts forecast the Global CD market to grow at a CAGR of 2.84 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global CD market for the period 2015–2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of CD. The Global CD market can be divided into five segments: 5-ASA, Antibiotics, Biologicals, Corticosteroids, and Immunomodulators.

TechNavio's report, the Global CD Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global CD market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key Regions

  • Americas
  • APAC
  • EMEA
Key Vendors
  • AbbVie
  • Astra Zeneca
  • Biogen Idec
  • Johnson & Johnson
  • Takeda Pharmaceutical
  • UCB
Other Prominent Vendors
  • Amgen
  • Boehringer Ingelheim
  • Celltrion
  • ChemoCentryx
  • Ferring Pharmaceuticals
  • Merck
  • Mitsubishi Tanabe
  • Novartis
  • Novo Nordisk
  • Pfizer
Market Driver
  • Increase in CD Prevalence
  • For a full, detailed list, view our report
Market Challenge
  • Multiple Patent Expiry
  • For a full, detailed list, view our report
Market Trend
  • Increase in Strategic Collaborations
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

TechNavio Announces the Publication of its Research Report – Global CD Market 2015-2019

TechNavio recognizes the following companies as the key players in the Global CD Market: AbbVie Inc., AstraZeneca plc, Biogen Idec Inc., Johnson & Johnson, Takeda Pharmaceutical Co. Ltd. and UCB SA

Other Prominent Vendors in the market are: Amgen, Boehringer Ingelheim, Celltrion, ChemoCentryx, Ferring Pharmaceuticals, Merck, Mitsubishi Tanabe, Novartis, Novo Nordisk and Pfizer.

Commenting on the report, an analyst from TechNavio’s team said: “An increase in strategic collaborations is one key trend being witnessed in the market. As a result of intense competition in the market, vendors are forming strategic alliances to increase their share in the market.”

According to the report, the high prevalence of CD has led to an increase in the number of medical prescriptions to treat the disease. Globally, the incidence rate for CD varied from 0.30 to 16.50 cases per 100,000 people annually.

Further, the report states that the expiry of patents results in the loss of exclusivity leading to a rapid decline in the sales of that specific drug in the market. The expiry of patents of major drugs leads to the development of their generic forms resulting in a fragmented market.

Companies Mentioned

AbbVie, Astra Zeneca, Biogen Idec, Johnson & Johnson, Takeda Pharmaceutical, UCB, Amgen, Boehringer Ingelheim, Celltrion, ChemoCentryx, Ferring Pharmaceuticals,Merck, Mitsubishi Tanabe, Novartis, Novo Nordisk, Pfizer

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
      • Product Profiles
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Disease Overview
    • Understanding the Disease
      • Table Overview of CD
      • Table Classification of CD
    • Etiology
      • Autoimmune Reaction
      • Genes
      • Environment
    • Stages of CD
    • Epidemiology
      • Worldwide Prevalence of CD
        • Table Expected Number of Global CD Cases 2015-2022
        • Table Global Variation in Incidence Rates for CD in 2012 (percent)
      • US
        • Table Prevalence of CD in US
        • Table Incidence of CD in US
      • UK
    • Symptoms
      • Table Symptoms of CD
      • Diarrhea
      • Fever and Fatigue
      • Abdominal Pain and Cramping
      • Perianal Disease and Blood in Stool
      • Reduced Appetite and Weight Loss
    • Diagnosis and Testing
      • Table CD: Diagnosis and Testing
      • Early Tests and Exams
      • Endoscopy and Biopsy
      • Chromoendoscopy
      • Small Intestinal Imaging
    • Treatment
      • Table CD: Treatment
      • Medication
        • Table Treatment Landscape for CD
      • Diet and Nutrition
      • Surgery
        • Table CD: Treatment Pathway
  • CD Pipeline Landscape
    • Some Emerging Therapeutic Options
      • Table CD Clinical Trials by Phase
      • Table CD Clinical Trials by Status
  • Market Landscape
    • Market Overview
      • Table Snapshot of Global CD Market 2014
    • Market Size and Forecast
      • Table Global CD Market 2014-2019 (US$ billion)
    • CD Market in US
      • Market Size and Forecast
        • Table CD Market in US 2014-2019 (US$ billion)
    • CD Market in Japan
      • Market Size and Forecast
        • Table CD Market in Japan 2014-2019 (US$ billion)
    • Five Forces Analysis
  • Market Segmentation by Drug Class
    • Table Segmentation of Global CD Market by Drug Class
    • Table Benefits and Risks of 5-ASA
  • Geographical Segmentation
    • Table Segmentation of Global CD Market by Geography 2014
  • Buying Criteria
  • Market Growth Drivers
  • Drivers and their Impact
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
    • Table Approved Biologics for CD
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2014
      • AbbVie
        • Table Global Revenue of Humira by AbbVie 2010-2013 (US$ million)
      • AstraZeneca
        • Table Revenue of AstraZeneca by Therapeutic Area 2013
      • Biogen Idec
        • Table Global Revenue of Tysabri by Biogen Idec 2011-2013 (US$ million)
        • Table Quarter Sales of Tysabri by Biogen Idec 2014 (US$ million)
      • Johnson & Johnson
        • Table Revenue of Johnson & Johnson by Therapeutic Area (Pharmaceuticals) 2013
        • Table Global Revenue of Remicade by Johnson & Johnson 2010-2013 (US$ million)
        • Table Global Revenue of Stelara by Johnson & Johnson 2010-2013 (US$ million)
      • Takeda Pharmaceutical
      • UCB
        • Table Global Revenue of Cimzia by UCB 2010-2013 (US$ million)
    • Other Prominent Vendors
  • Key Vendor Analysis
    • AbbVie
      • Key Facts
      • Business Overview
      • Product Segmentation by Revenue 2013
        • Table AbbVie Inc.: Product Segmentation by Revenue 2013
      • Product Segmentation by Revenue 2012 and 2013
        • Table AbbVie Inc.: Product Segmentation by Revenue 2012 and 2013 (US$ million)
      • Sales by Geography
        • Table AbbVie Inc.: Sales by Geography 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • AstraZeneca plc
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table AstraZeneca plc: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2011-2013
        • Table AstraZeneca plc: Business Segmentation by Revenue 2011-2013 (US$ million)
      • Sales by Geography
        • Table AstraZeneca plc: Sales by Geography 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • Biogen Idec
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Biogen Idec: Business Segmentation by Revenue 2013
      • Geographical Segmentation by Revenue 2013
        • Table Biogen Idec: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • Johnson & Johnson
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Johnson & Johnson: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
      • Geographical Segmentation by Revenue 2013
        • Table Johnson & Johnson: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Takeda Pharmaceuticals
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Takeda Pharmaceuticals: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2013
        • Table Takeda Pharmaceuticals: Business Segmentation by Revenue 2013 (US$ million)
      • Geographical Segmentation by Revenue 2013
        • Table Takeda Pharmaceuticals: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • UCB
      • Key Facts
      • Business Overview
      • Product Segmentation by Revenue 2013
        • Table UCB: Product Segmentation by Revenue 2013
      • Product Segmentation by Revenue 2012 and 2013
        • Table UCB: Product Segmentation by Revenue 2012 and 2013 (US$ million)
      • Geographical Segmentation by Revenue 2013
        • Table UCB: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report